| dimeric antigen receptor (DAR) |
2023-10-04 |
2023-11-24 |
|
| Cd38 antibody-drug conjugates |
2023-8-14 |
2023-10-02 |
|
| Folate-conjugated drugs and uses thereof |
2023-7-24 |
2024-2-01 |
|
| Method for treating inflammatory dysfunction of the oral mucosa |
2023-5-31 |
2023-12-07 |
|
| Antigen binding proteins that bind pd-1 |
2023-5-25 |
2023-7-13 |
|
| Antibody-drug conjugates comprising an anti-folr1 antibody |
2023-5-09 |
2023-11-16 |
|
| Sample collection and concentration device and methods of its use |
2023-4-26 |
2023-11-02 |
|
| Oral delayed burst formulation of low-dose naltrexone and methods for treating … |
2023-4-05 |
2023-11-23 |
|
| Antibody-drug conjugates and uses thereof |
2023-3-09 |
2023-9-14 |
|
| Novel ionizable cationic lipids |
2023-2-23 |
2023-8-31 |
|
| Antigen binding proteins that bind b7-h3 |
2023-2-03 |
2023-8-10 |
|
| Application device for a fluid delivery apparatus and method of use |
2023-1-19 |
2023-5-18 |
|
| Neutralizing antibodies and antigen-binding fragments thereof against omicron … |
2023-1-18 |
2023-7-27 |
|
| Engineered pd-l1-targeting gamma delta t cell receptors |
2023-1-06 |
2023-7-13 |
|
| Device for delivery of rheumatoid arthritis medication |
2022-12-29 |
2023-5-04 |
|
| Methods for lymphatic delivery of active agents |
2022-11-21 |
2023-1-05 |
|
| Methods for better delivery of active agents to tumors |
2022-11-21 |
2023-1-05 |
|
| Formulation of resiniferatoxin |
2022-10-07 |
2022-11-25 |
|
| Method of creating an animal model of chronic disease exacerbation by acute … |
2022-10-06 |
2023-4-13 |
|
| Therapeutic agents targeting the lymphatic system |
2022-8-16 |
2023-2-23 |
|
| Therapeutic agents targeting the lymphatic system |
2022-8-16 |
2023-2-23 |
|
| Dimeric Antigen Receptors (DAR) That Bind CD20 |
2022-8-16 |
2023-3-02 |
|
| Antigen binding proteins that bind PD-L1 |
2022-6-27 |
2022-7-28 |
|
| Intracellular delivery compounds |
2022-6-24 |
2022-9-06 |
|
| Antibody therapeutics that bind cd38 |
2022-6-23 |
2022-8-12 |
|
| Antibody-drug conjugates comprising an anti-bcma antibody |
2022-6-21 |
2023-9-01 |
|
| Administration of resiniferatoxin for treatment of pancreatic cancer |
2022-6-10 |
2022-12-15 |
|
| Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 … |
2022-6-08 |
2024-1-25 |
|
| Protease inhibitors as antivirals |
2022-6-01 |
2023-1-26 |
|
| Method for administering medicament suitable for treating migraine or cluster … |
2022-5-27 |
2022-8-17 |
|
| Transdermal drug delivery apparatus and methods |
2022-5-19 |
2022-7-07 |
|
| Presurgical perineural administration of resiniferatoxin for reduction of post- … |
2022-5-17 |
2022-11-24 |
|
| Neutralizing antibodies that bind variant sars-cov-2 spike proteins |
2022-5-05 |
2022-11-10 |
|
| Fluid delivery apparatus having a controller assembly and method of use |
2022-5-05 |
2022-11-10 |
|
| Dimeric antigen receptors (dars) that bind gd2 |
2022-4-22 |
2022-10-27 |
|
| Antigen binding proteins that bind to pd-l1 |
2022-4-15 |
2022-6-28 |
|
| Oncolytic viruses expressing anti-ror1/anti-cd3 bispecific antibodies |
2022-4-08 |
2022-10-13 |
|
| Antigen binding proteins that bind ror1 |
2022-4-08 |
2022-10-13 |
|
| Microneedle array assembly, drug delivery device and method for administering … |
2022-4-08 |
2022-4-28 |
|
| Intracellular internalization conjugate containing thiol-reactive groups for … |
2022-4-04 |
2022-6-21 |
|
| Antibody therapeutics that bind to ctla4 |
2022-4-01 |
2022-6-07 |
|
| Microneedle array assembly and fluid delivery apparatus having such an assembly |
2022-3-21 |
2022-7-07 |
|
| Nucleic acid molecules and vaccines comprising same for the prevention and … |
2022-3-10 |
2022-9-15 |
|
| Dimeric Antigen Receptors (DAR) that Bind BCMA |
2022-3-03 |
2022-8-11 |
|
| Antibody-drug conjugates comprising an anti-bcma antibody |
2022-3-02 |
2022-9-09 |
|
| Antibody-drug conjugates comprising an anti-bcma antibody |
2022-3-02 |
2023-1-16 |
|
| Administration of resiniferatoxin for treatment of prostate cancer |
2022-2-10 |
2022-8-18 |
|
| Administration of resiniferatoxin for the treatment of prostate cancer |
2022-2-10 |
2024-2-16 |
|
| FLUID DELIVERY DEVICE WITH GAS EXTRACTION DEVICE AND METHOD OF USE THEREOF |
2022-2-08 |
2023-7-12 |
2023-7-12 |
| Chemically-Locked Bispecific Antibodies |
2022-1-26 |
2022-5-12 |
|
| Device for microliter-scale lymphatic delivery of coronavirus vaccines |
2022-1-21 |
2023-11-29 |
|
| Methods, assays and systems for detecting target analytes |
2022-1-13 |
2023-11-28 |
|
| Methods, assays and systems for detecting target analytes |
2022-1-13 |
2024-1-23 |
|
| Heterodimeric antibodies that bind to cd38 and cd3 |
2021-12-29 |
2022-2-01 |
|
| Antibody therapeutics that bind cd47 |
2021-11-09 |
2022-1-01 |
|
| Lateral flow devices for high sensitivity detection of coronavirus infection, … |
2021-11-03 |
2023-9-13 |
|
| Nanopatterned medical device with enhanced cellular interaction |
2021-10-19 |
2022-2-10 |
|
| Antibody therapeutics that bind cd137 |
2021-10-12 |
2022-1-27 |
|
| Activatable multi-specific antigen binding protein complexes |
2021-10-11 |
2021-12-01 |
|
| Cd19-directed chimeric antigen receptor constructs |
2021-10-11 |
2022-4-21 |
|
| Salicylanilide analogs for use in the treatment of coronavirus |
2021-10-06 |
2022-4-14 |
|
| Antigen Binding Proteins that Bind c-Met |
2021-9-22 |
2022-1-06 |
|
| Improved process for integration of dna constructs using rna-guided … |
2021-9-09 |
2021-10-31 |
|
| Antibody-drug conjugates with derivatives of amatoxin as drugs |
2021-9-02 |
2023-12-22 |
2023-12-22 |
| MEDICAL DEVICES FOR DELIVERY OF siRNA |
2021-9-01 |
2021-12-23 |
|
| Antigen Binding Proteins that Bind BCMA |
2021-8-25 |
2021-12-16 |
|
| Improved process for dna integration using rna-guided endonucleases |
2021-8-24 |
2021-10-31 |
|
| Variant antibodies that bind ox40 |
2021-8-23 |
2021-12-23 |
|
| Transdermal delivery of high viscosity bioactive agents |
2021-8-23 |
2022-1-13 |
|
| Treating Pulmonary Inflammatory Disease by Neural Ablation |
2021-8-10 |
2023-9-28 |
|
| Neutralizing antibodies that bind the sars-cov-2 s protein |
2021-8-06 |
2022-6-01 |
|
| Implantable devices for delivery of bioactive agents |
2021-8-02 |
2021-12-30 |
|
| Fully Human Antibodies That Bind to Vascular Endothelial Growth Factor Receptor … |
2021-7-29 |
2022-1-27 |
|
| Method for treating osteoarthritis pain by administering resiniferatoxin |
2021-7-19 |
2021-9-30 |
|
| Improved process for dna integration using rna-guided endonucleases |
2021-7-15 |
2022-1-20 |
|
| Anti-pd1 antibodies and uses thereof |
2021-6-25 |
2022-5-01 |
|
| Oncolytic herpes simplex viruses (HSV) expressing immunomodulatory fusion … |
2021-6-25 |
2023-2-23 |
|
| Administration of Resiniferatoxin For Treatment of Bladder Pain or Bladder … |
2021-6-18 |
2023-8-31 |
|
| Perineural administration of resiniferatoxin for treatment of maladaptive pain |
2021-6-13 |
2021-7-29 |
|
| Methods for Treating Parkinson?s Disease by Administering Resiniferatoxin |
2021-6-11 |
2021-9-30 |
|
| Cartridge portion of transdermal drug delivery apparatus and methods |
2021-6-01 |
2021-7-01 |
|
| Neutralizing antibodies that bind the sars-cov-2 s protein |
2021-5-05 |
2021-11-11 |
|
| Lateral Flow Device for Detection of Neutralizing Antibodies Against SARS-COV-2 |
2021-4-23 |
2023-6-01 |
|
| Memory dimeric antigen receptors |
2021-4-23 |
2021-10-28 |
|
| Pulmonary Administration of ACE2 Polypeptides |
2021-4-20 |
2023-5-25 |
|
| Engineered antibodies that bind lag3 |
2021-4-01 |
2022-2-01 |
|
| Fc-coronavirus antigen fusion proteins, and nucleic acids, vectors, … |
2021-3-23 |
2021-9-30 |
|
| Treating pulmonary inflammatory disease associated with covid-19 by … |
2021-3-12 |
2023-2-08 |
|
| Innate Immunity Killer Cells Targeting PSMA Positive Tumor Cells |
2021-3-05 |
2023-3-30 |
|
| Activatable antigen binding proteins with universal masking moieties |
2021-2-24 |
2023-6-15 |
|
| Transdermal drug delivery device |
2021-2-18 |
2021-6-10 |
|
| Natural killer cells for treatment of coronavirus infection |
2021-1-27 |
2021-8-05 |
|
| Antibody therapeutics that bind CD123 |
2021-1-15 |
2023-9-05 |
2023-9-05 |
| Variant Antibody That Binds Cd38 |
2020-12-18 |
2021-5-06 |
|
| Compositions and methods comprising an anti-cd47 antibody in combination with a … |
2020-12-04 |
2021-6-10 |
|
| Placenta-derived allogeneic CAR-T cells and uses thereof |
2020-12-04 |
2022-8-05 |
|
| Method for treating cancer by administration of anti-PD-1 or anti-PD-L1 … |
2020-12-04 |
2023-2-08 |
|
| Fluid delivery device with microneedles |
2020-12-02 |
2023-2-06 |
|
| Drug delivery methods targeting the lymphatic system |
2020-11-26 |
2021-1-31 |
|
| Drug-Conjugates With a Targeting Molecule and Two Different Drugs |
2020-9-29 |
2021-1-21 |
|